10/08/2026
The antigen supply challenge isn't going away, it's evolving.
Growing diagnostic demand is placing increasing pressure on traditional native antigen production. By incorporating recombinant antigens into your strategy, you can build a more predictable, scalable supply chain without compromising performance.
Ready to strengthen your diagnostic pipeline? Connect with our experts to explore the right solution for your business.
Get in touch: https://eu1.hubs.ly/H0xtM7b0